News

Discussing the implications and future of wearable technology after the release of the Apple Heart Study.

A new cohort shows that though most physicians stay in medicine after receiving multiple paid malpractice claims, they often end up working in a more isolated setting.

New research shows the public increasingly sees e-cigarettes as equally unhealthy compared to cigarettes—but that’s not the whole picture.

The application to the FDA for icosapent ethyl seeks a new indication to reduce the risk of major adverse cardiovascular events.

What sort of problems will orthopedic surgeons face in the future and how has the average patient changed in recent years?

MD Magazine sat down with Chirag Barbhaiya, MD, of NYU Langone Health, to discuss the updated guidelines for treating a patient with Afib.

The American Academy of Pediatrics says the nasal spray is an acceptable option for influenza vaccination in the coming flu season.

A fourth phase 3 study of investigational drug SPN-812 demonstrated a significant decrease in ADHD-RS-5 scores compared to placebo.

The canagliflozin (Invokana) application seeks a new indication to treat chronic kidney disease in patients with type 2 diabetes.

A new cohort assessment shows white and African American men both have a lifetime hypertension risk of more than 80%.

Investigators recognize sustained virologic response to DAAs for hepatitis C infection as valid clinical endpoint of treatment, but question how it relates to long-term health.

Jatenzo's label will be marketed with a boxed warning stating it can cause risen blood pressure, thereby increasing heart attack, stroke, and cardiovascular death risks.

Higher exposure to air pollutants, especially NO2 and NOx, was found to be associated with greater odds of psychotic experiences in adolescents.

Investigators observed a 22% and 20% increased risk of heart failure during the 2 most severe influenza seasons.

Siponimod becomes first oral drug to treat secondary progressive MS to receive FDA approval.

Just 7 other states, and the District of Columbia, have passed such a law before. The bill's parameters are similar to that of Hawaii's, which passed its own law last year.

The best way to diagnose diabetic macular edema is using optical coherence tomography, but it is costly.

A short account of patients I’ve known and not loved over the years.

After demonstrating success of direct-acting antivirals for HCV in cancer patients, investigators call for their eligibility to participate in chemo trials.

The investigative solution improved patient metrics for itching, and could be considered for FDA submission later this year.

More than 80% of patients saw maintenance or improvement of BCVA, with a mean improvment of 7 letters or more, according to the ETDRS system.

Aimmune announced AR101 phase 3 trial reached its primary efficacy endpoint, intent to submit marketing authorization application.

The investigational anti-fibrotic immunomodulator is being investigated for respiratory, oncology, hepatology, and nephrology indications.

Though it has been shown to not be harmful to patients at risk for the opitcal condition, calcium may still play a protective role in these patients.

How care providers can improve their perspective and better their stress with some volunteer work where it's needed most.

Scientists at the Task Force for Global Health describe what is needed to eliminate HBV and HCV as public health threats.

One evaluated dose of AVP-786 significantly improved scores in patients with moderate-to-severe agitation related to Alzheimer dementia, compared to placebo.

First RCT to determine the efficacy of wearable digital intervention to improve social behavior of children with autism spectrum disorder.